• Explore /
  • Poster
  • / Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).

Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).

Abstract Poster

Authors

null

Sally Leong

Harbor-UCLA Medical Center, Torrance, CA

Sally Leong , Sana Ali , Zeynep Busra Zengin , Luis A Meza , Nazli Dizman , Hedyeh Ebrahimi , Ameish Govindarajan , Daniela V. Castro , Xiaochen Li , Tane Kim , Sam Melamed , Mykola Onyshchenko , Sumanta Monty Pal , Alex Chehrazi-Raffle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Cancer Disparities

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 613)

DOI

10.1200/JCO.2023.41.6_suppl.613

Abstract #

613

Poster Bd #

E3

Abstract Disclosures

Similar Posters

First Author: Chun Loo Gan

First Author: Sana Ali

First Author: Connor Wells

Poster

2024 ASCO Genitourinary Cancers Symposium

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

First Author: Regina Barragan-Carrillo